Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Anaplastic Astrocytoma
Regimen:
(lomustine + Matulane (procarbazine hydrochloride) + vincristine)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
ASCO.org
Excerpt:
...while no benefit has been demonstrated for adjuvant PCV chemotherapy (procarbazine, lomustine [CCNU], vincristine) in anaplastic astrocytoma…
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
ESMO.org
Excerpt:
...while no benefit has been demonstrated for adjuvant PCV chemotherapy (procarbazine, lomustine [CCNU], vincristine) in anaplastic astrocytoma…
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login